scispace - formally typeset
Open AccessJournal ArticleDOI

Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation.

TLDR
The roles of gut microbial SCFAs in the host energy regulation are summarized and an overview of the current understanding of its physiological functions is presented.
Abstract
During feeding, the gut microbiota contributes to the host energy acquisition and metabolic regulation thereby influencing the development of metabolic disorders such as obesity and diabetes. Short-chain fatty acids (SCFAs) such as acetate, butyrate, and propionate, which are produced by gut microbial fermentation of dietary fiber, are recognized as essential host energy sources and act as signal transduction molecules via G-protein coupled receptors (FFAR2, FFAR3, OLFR78, GPR109A) and as epigenetic regulators of gene expression by the inhibition of histone deacetylase (HDAC). Recent evidence suggests that dietary fiber and the gut microbial-derived SCFAs exert multiple beneficial effects on the host energy metabolism not only by improving the intestinal environment, but also by directly affecting various host peripheral tissues. In this review, we summarize the roles of gut microbial SCFAs in the host energy regulation and present an overview of the current understanding of its physiological functions.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Probiotics and prebiotics in intestinal health and disease: from biology to the clinic

TL;DR: Gut-derived effects in humans is described, a review of current understanding of probiotics and prebiotics as a means to manage the microbiota to improve host health, including mechanisms of actions and potential for clinical use.
Journal ArticleDOI

Gut Microbiome: Profound Implications for Diet and Disease

TL;DR: The role of diet quality, carbohydrate intake, fermentable FODMAPs, and prebiotic fiber in maintaining healthy gut flora is reviewed and the implications are discussed for various conditions including obesity, diabetes, irritable bowel syndrome, inflammatory bowel disease, depression, and cardiovascular disease.
Journal ArticleDOI

Free Fatty Acid Receptors in Health and Disease.

TL;DR: Recent reports on the key physiological functions of the FFAR-mediated signaling transduction pathways in the regulation of metabolism and immune responses are discussed and future research opportunities for developing therapeutics for metabolic and immune disorders are revealed.
Journal ArticleDOI

The microbiome: A key regulator of stress and neuroinflammation

TL;DR: The mechanisms by which commensal gut microbiota can regulate neuroinflammation are focused on and the understanding of their role in stress-related disorders as a consequence of neuroinflammatory processes is exploited.
Journal ArticleDOI

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.

TL;DR: The gut microbiota is essential to health and has recently become a target for live bacterial cell biotherapies for various chronic diseases including metabolic syndrome, diabetes, obesity and neurodegenerative disease, where the management of the gut microbiota may prevent or alleviate the symptoms of these chronic diseases.
References
More filters
Journal ArticleDOI

An obesity-associated gut microbiome with increased capacity for energy harvest

TL;DR: It is demonstrated through metagenomic and biochemical analyses that changes in the relative abundance of the Bacteroidetes and Firmicutes affect the metabolic potential of the mouse gut microbiota and indicates that the obese microbiome has an increased capacity to harvest energy from the diet.
Journal ArticleDOI

Microbial ecology: Human gut microbes associated with obesity

TL;DR: It is shown that the relative proportion of Bacteroidetes is decreased in obese people by comparison with lean people, and that this proportion increases with weight loss on two types of low-calorie diet.
Journal ArticleDOI

Mechanisms linking obesity to insulin resistance and type 2 diabetes

TL;DR: In obese individuals, adipose tissue releases increased amounts of non-esterified fatty acids, glycerol, hormones, pro-inflammatory cytokines and other factors that are involved in the development of insulin resistance.
Related Papers (5)